Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Chemical Science|April 19, 2019
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase AktNiklas Uhlenbrock, Steven Smith, Jörn Weisner, et al.
Anti-Cancer Drugs|March 7, 2024
A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumorsAndrew S Poklepovic, Sarah W Gordon, Sejal Kothadia, et al.
Clinical and Translational Science|November 13, 2024
A randomized, placebo-controlled first-in-human study of oral TQS-168 in healthy volunteers: Assessment of safety, tolerability, pharmacokinetics, pharmacodynamics, and food effectJonas Hannestad, Steven Smith, Andrew Lam, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 17, 2022
Enterprise risk management for automation in correctional facilities with pandemic and other stressorsDaniel J Andrews, Timothy L Eddy, Kelsey S Hollenback, et al.
Frontiers in Immunology|June 2, 2020
Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in UgandaLawrence Lubyayi, Patrice A Mawa, Grace Nabakooza, et al.
Scientific Reports|December 8, 2016
Diverse specificity of cellulosome attachment to the bacterial cell surfaceJoana L A Brás, Benedita A Pinheiro, Kate Cameron, et al.
The Lancet. Oncology|April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
Cancer Research Communications|March 29, 2024
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid TumorsMark Yarchoan, John D Powderly, Bruno R Bastos, et al.
Mabs|December 15, 2015
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsCon Panousis, Urmi Dhagat, Kirsten M Edwards, et al.
Cell Reports|April 30, 2020
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLCCaroline Volz, Sara Breid, Carolin Selenz, et al.
Pageof 15